Next |
home / stock / ptgx / ptgx message board
Subject | By | Source | When |
---|---|---|---|
znewcar1: $PTGX 51% v22,7M c23.09 f49,198M H23.69 ML14.93 RL15.01 gapNgo | znewcar1 | investorshangout | 03/07/2023 10:01:06 PM |
Looks like I left $3 early but made | ErnieBilco | investorshub | 03/07/2023 8:36:06 PM |
Well I let mine go today @ $20 | ErnieBilco | investorshub | 03/07/2023 6:08:53 PM |
Pulled from yahoo finance...this stock could explode 4x | ziggy7796 | investorshub | 04/27/2022 11:13:06 AM |
Just...pulled this...ziggy. Protagonist Therapeutics:Biotechnology companyP | ziggy7796 | investorshub | 04/26/2022 3:13:42 PM |
Trading volume picking up...let's see what happens. | ziggy7796 | investorshub | 04/26/2022 3:02:29 PM |
Also....2.5 million shares traded is low for a | ziggy7796 | investorshub | 04/26/2022 2:47:06 PM |
Watch what happens in the next 4 hrs.....I | ziggy7796 | investorshub | 04/26/2022 2:44:44 PM |
I'm bewildered because their Ph2 results were very | ErnieBilco | investorshub | 04/26/2022 2:30:07 PM |
Not sure....I thought buying back at 12 was | ziggy7796 | investorshub | 04/26/2022 2:24:59 PM |
OMG, what a massacre - Is it a | ErnieBilco | investorshub | 04/26/2022 2:01:50 PM |
This has potential to rebound nicely after Thursdays | ziggy7796 | investorshub | 04/18/2022 2:25:19 PM |
I sold 500 shares. See Dew @ Bio | north40000 | investorshub | 04/13/2022 11:31:31 PM |
That would do it - thanks | ErnieBilco | investorshub | 04/13/2022 11:28:19 PM |
FDA revoked break-through therapy designation for one of | north40000 | investorshub | 04/13/2022 11:26:29 PM |
Just bought back in after a long hiatis | ErnieBilco | investorshub | 04/13/2022 10:12:05 PM |
Continued movement upward in advance of conference. | ok2buy | investorshub | 11/10/2021 3:03:36 PM |
Great news yesterday. Company will be presenting | ok2buy | investorshub | 11/05/2021 1:11:26 PM |
Open down, then up, now back down again. | ok2buy | investorshub | 10/13/2021 2:09:58 PM |
I agree. pullback was to be expected. | rib eye | investorshub | 10/12/2021 8:42:36 PM |
News, Short Squeeze, Breakout and More Instantly...
Protagonist Therapeutics Inc. Company Name:
PTGX Stock Symbol:
NASDAQ Market:
Protagonist Therapeutics Inc. Website:
Dr. Yeilding joins Protagonist from Janssen Pharmaceutical Companies of Johnson & Johnson, where he held leadership roles in the immunology therapeutic area, bringing extensive experience in R&D and commercialization of novel therapeutics in the I&I space NEWARK, CA / ACCESSWIRE /...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 75.8% to $0.0457 on volume of 1,196,767,473 shares NVIDIA Corporation (NVDA) fell 6.8% to $114.25 on volume of 316,196,296 shares Sangamo Therapeutics Inc. (SGMO) rose 39.5% to $0.56 on volume of 261...
NEWARK, CA / ACCESSWIRE / July 22, 2024 / Protagonist Therapeutics, Inc. (NASDAQ:PTGX) ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., President and Chief Executive Officer, will participate in a fireside chat and one-on-one meetings at the BTIG Virtual Biotechnolog...